Growth Metrics

DBV Technologies (DBVT) Non-Current Assets (2014 - 2026)

DBV Technologies (DBVT) reported Non-Current Assets of $19.7 million for Q1 2026, down 8.0% year-over-year from $21.4 million in Q1 2025, and down 5.29% on a QoQ basis from $20.8 million in Q4 2025.

DBV Technologies (DBVT) has 13 years of Non-Current Assets data on file, last reported at $19.7 million in Q1 2026.

  • Quarterly Non-Current Assets fell 8.0% year-over-year to $19.7 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $19.7 million (down 8.0% YoY) and the FY2025 annual result came in at $20.8 million, down 2.21% from the prior year.
  • Non-Current Assets declined to $19.7 million in Q1 2026 per DBVT's latest filing, from $20.8 million in the prior quarter.
  • Across five years, Non-Current Assets topped out at $27.1 million in Q1 2022 and bottomed at $19.7 million in Q1 2026.
  • The 5-year median for Non-Current Assets is $22.4 million (2022), against an average of $22.9 million.
  • The widest annual swing landed in 2022, when Non-Current Assets plunged 63.11%; it then grew 18.44% in 2024.
  • Tracing DBVT's Non-Current Assets over 5 years: stood at $23.4 million in 2022, then increased by 2.67% to $24.1 million in 2023, then slipped by 11.63% to $21.3 million in 2024, then fell by 2.21% to $20.8 million in 2025, then retreated by 5.29% to $19.7 million in 2026.
  • Per Business Quant, the three latest DBVT Non-Current Assets figures stand at $19.7 million (Q1 2026), $20.8 million (Q4 2025), and $21.6 million (Q3 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Current Assets (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn - 4.56 Mn
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn - 62,953.78
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn 486.60 Mn
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn - 5.83 Mn
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn - 30.30 Mn
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn 14.75 Bn
7 Evaxion A 62.56 Bn 62.54 Bn - -
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn 22.66 Bn
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn 910.24 Mn
10 DBV Technologies 8.00 Bn 7.77 Bn -3.90 Mn 19.70 Mn

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 19.70 Mn
Dec 31, 2025 20.80 Mn
Sep 30, 2025 21.61 Mn
Jun 30, 2025 22.19 Mn
Mar 31, 2025 21.41 Mn
Dec 31, 2024 21.27 Mn
Sep 30, 2024 24.30 Mn
Jun 30, 2024 24.23 Mn
Mar 31, 2024 26.33 Mn
Dec 31, 2023 24.07 Mn
Sep 30, 2023 20.51 Mn
Jun 30, 2023 21.98 Mn
Mar 31, 2023 22.69 Mn
Dec 31, 2022 23.44 Mn
Sep 30, 2022 22.42 Mn
Jun 30, 2022 25.03 Mn
Mar 31, 2022 27.14 Mn
Dec 31, 2021 32.34 Mn
Sep 30, 2021 60.79 Mn
Jun 30, 2021 61.99 Mn
Mar 31, 2021 61.60 Mn
Dec 31, 2020 64.87 Mn
Jun 30, 2020 67.97 Mn
Dec 31, 2019 65.74 Mn
Sep 30, 2019 64.33 Mn
Jun 30, 2019 55.21 Mn
Dec 31, 2018 30.00 Mn
Jun 30, 2018 23.86 Mn
Dec 31, 2017 24.66 Mn
Jun 30, 2017 20.39 Mn
Dec 31, 2016 16.54 Mn
Jun 30, 2016 14.99 Mn
Dec 31, 2015 9.19 Mn
Jun 30, 2015 4.79 Mn
Dec 31, 2014 4.81 Mn